The role of extracellular ATP in regulating the functional activity of cells
https://doi.org/10.18699/SSMJ20240506
Abstract
A search and analysis of scientific articles presented in the databases PubMed, ScienceDirect, Elsevier, eLibrary for 2000–2024 was carried out. The selection criterion was the presence in the articles of information on the concentration of extracellular ATP in normal and pathological tissues, the mechanisms of purinergic regulation of cell functioning, and the expression of CD73 and CD39 ectonucleotidases on cells, which regulate proinflammatory extracellular ATP catabolism to immunosuppressive adenosine. Modern data are presented on the role of extracellular ATP in the regulation of cell functioning under normal and pathological conditions, during inflammation and the formation of cellular and humoral immune responses, as well as on the study of the mechanisms of purinergic signaling from extracellular ATP in the development of targeted drugs for various diseases, including neoplasms, neurodegenerative and autoimmune pathologies.
About the Author
V. P. PatrakeevaRussian Federation
Veronika P. Patrakeeva, candidate of biological sciences
163065 Arkhangelsk, Nikolsky ave., 20
References
1. Eltzschig H.K., Sitkovsky M.V., Robson S.C. Purinergic signaling during inflammation. N. Engl. J. Med. 2012;367(24):2322–2333. doi: 10.1056/NEJMra1205750
2. Jiang L., Chen H.Y., He C.H., Xu H.B., Zhou Z.R., Wu M.S., Fodjo E.K., He Y., Hafez M.E., Qian R.C., Li D.W. Dual-modal apoptosis assay enabling dynamic visualization of ATP and reactive oxygen species in living cells. Anal. Chem. 2023;95(6):3507–3515. doi: 10.1021/acs.analchem.2c05671
3. Hasuzawa N., Moriyama S., Moriyama Y., Nomura M. Physiopathological roles of vesicular nucleotide transporter (VNUT), an essential component for vesicular ATP release. Biochim. Biophys. Acta Biomembr. 2020;1862(12):183408. doi: 10.1016/j.bbamem.2020.183408
4. Moriyama Y., Hiasa M., Sakamoto S., Omote H., Nomura M. Vesicular nucleotide transporter (VNUT): appearance of an actress on the stage of purinergic signaling. Purinergic. Signalling. 2017;13(3):387–404. doi: 10.1007/s11302-017-9568-1
5. Gorelik J., Zhang Y., Sanchez D., Shevchuk A., Frolenkov G., Lab M., Klenerman D., Edwards C., Korchev Y. Aldosterone acts via an ATP autocrine/ paracrine system: the Edelman ATP hypothesis revisited. Pro.c Natl. Acad. Sci. USA. 2005;102(42):15000–15005. doi: 10.1073/pnas.0507008102
6. Ismaeel S., Qadri A. ATP release drives inflammation with lysophosphatidylcholine. Immunohorizons. 2021;5(4):219–233. doi: 10.4049/immunohorizons.2100023
7. Seminario-Vidal L., Kreda S., Jones L., O’Neal W., Trejo J., Boucher R.C., Lazarowski E.R. Thrombin promotes release of ATP from lung epithelial cells through coordinated activation of Rhoand Ca2+-dependent signaling pathways. J. Biol. Chem. 2009;284(31):20638–20648. doi: 10.1074/jbc.M109.004762
8. Moritz C.E., Teixeira B.C., Rockenbach L., Reischak-Oliveira A., Casali E.A., Battastini A.M. Altered extracellular ATP, ADP, and AMP hydrolysis in blood serum of sedentary individuals after an acute, aerobic, moderate exercise session. Mol. Cell. Biochem. 2017;426(1-2):55–63. doi: 10.1007/s11010-016-2880-1
9. Sladkova E.A. Influence of the purinergic signaling system on the properties of human blood cells at ageing. Zhurnal mediko-biologicheskikh issledovaniy = Journal of Medical and Biological Research. 2021;9(1):51– 57. [In Russian]. doi: 10.37482/2687-1491-Z043
10. Antonioli L., Pacher P., Vizi E.S., Hasko G. CD39 and CD73 in immunity and inflammation. Trends Mol. Med. 2013;19(6):355–367. doi: 10.1016/j.mol-med.2013.03.005
11. Sperber H.S., Raymond K.A., Bouzidi M.S., Ma T., Valdebenito S., Eugenin E.A., Roan N.R., Deeks S.G., Winning S., Fandrey J., Schwarzer R., Pillai S. The hypoxia-regulated ectonucleotidase CD73 is a host determinant of HIV latency. Сell Rep. 2023;42(11):113285. doi: 10.1016/j.cel-rep.2023.113285
12. Kobayashi D., Umemoto E., Miyasaka M. The role of extracellular ATP in homeostatic immune cell migration. Curr. Opin Pharmacol. 2023;68:102331. doi: 10.1016/j.coph.2022.102331
13. Ledderose C., Bromberger S., Slubowski C.J., Sueyoshi K., Aytan D., Shen Y., Junger W.G. The purinergic receptor P2Y11 choreographs the polariza-tion, mitochondrial metabolism, and migration of T lymphocytes. Sci. Signal. 2020;13(651):eaba3300. doi: 10.1126/scisignal.aba3300
14. Ledderose C., Liu K., Kondo Y., Slubowski C.J., Dertnig T., Denicoló S., Arbab M., Hubner J., Konrad K., Fakhari M., … Junger W.G. Purinergic P2X4 receptors and mitochondrial ATP production regulate T cell migration. J. Clin. Invest. 2018;128(8): 3583–3594. doi: 10.1172/JCI120972
15. Gurusamy M., Tischner D., Shao J., Klatt S., Zukunft S., Bonnavion R., Günther S., Siebenbrodt K., Kestner R.I., Kuhlmann T., … Wettschureck N. G-protein-coupled receptor P2Y10 facilitates chemokine-induced CD4 T cell migration through autocrine/paracrine mediators. Nat. Commun. 2021;12(1):6798–6814. doi: 10.1038/s41467-021-26882-9
16. Burnstock G., Boeynaems J.M. Purinergic signalling and immune cells. Purinergic Signal. 2014;10(4):5229–5564. doi: 10.1007/s11302-014-9427-2
17. Junger W.G. Immune cell regulation by autocrine purinergic signaling. Nat. Rev. Immunol. 2011;11(3):201–212. doi: 10.1038/nri2938
18. Ledderose C., Junger W.G. Mitochondria synergize with P2 receptors to regulate human T cell function. Front. Immunol. 2020;11:549889. doi: 10.3389/fimmu.2020.549889
19. Quiroga J., Alarcón P., Manosalva C., Taubert A., Hermosilla C., Hidalgo M.A., Carretta M.D., Burgos R.A. Mitochondria-derived ATP participates in the formation of neutrophil extracellular traps induced by platelet-activating factor through purinergic signaling in cows. Dev. Comp. Immunol. 2020;113:103768. doi: 10.1016/j.dci.2020.103768
20. Adrover J.M., McDowell S.A.C., He X.Y., Quail D.F., Egeblad M. NETworking with cancer: The bidirectional interplay between cancer and neutrophil extracellular traps. Cancer Cell. 2023;41(3):505–526. doi: 10.1016/j.ccell.2023.02.001
21. Bastid J., Cottalorda-Regairaz A., Alberici G., Bonnefoy N., Eliaou J.F., Bensussan A. ENTPD1/CD39 is a promising therapeutic target in oncology. Oncogene. 2013;32(14):1743–1751. doi: 10.1038/onc.2012.269
22. Nikolova M., Carriere M., Jenabian M.A., Limou S., Younas M., Kök A., Huë S., Seddiki N., Hulin A., Delaneau O., … Lévy Y. CD39/adenosine pathway is involved in AIDS progression. PLoS Pathog. 2011;7(7):e1002110. doi: 10.1371/journal.ppat.1002110
23. Guzman-Flores J.M., Cortez-Espinosa N., Cortés-Garcia J.D., Vargas-Morales J.M., Cataño-Cañizalez Y.G., Rodríguez-Rivera J.G., Portales-Perez D.P. Expression of CD73 and A2A receptors in cells from subjects with obesity and type 2 diabetes mellitus. Immunobiology. 2015;220(8):976–984. doi: 10.1016/j.imbio.2015.02.007
24. Radygina T.V., Kuptsova D.G., Petrichuk S.V., Semikina E.L., Fisenko A.P. Expression of CD39 and CD73 ectonucleotidases in CD4+ lymphocyte populations in healthy children. Rossiyskiy immunologicheskiy zhurnal = Russian Journal of Immunology. 2022;25(3):283–290. [In Russian]. doi: 10.46235/1028-7221-1155-EOC
25. Chiarella A.M., Ryu Y.K., Manji G.A., Rustgi A.K. Extracellular ATP and adenosine in cancer pathogenesis and treatment. Trends Cancer. 2021;7(8):731–750. doi: 10.1016/j.trecan.2021.04.008
26. Hu L.P., Zhang X.X., Jiang S.H., Tao L.Y., Li Q., Zhu L.L., Yang M.W., Huo Y.M., Jiang Y.S., Tian G.A., … Zhang Z.G. Targeting purinergic receptor P2Y2 prevents the growth of pancreatic ductal adenocarcinoma by inhibiting cancer cell glycolysis. Clin. Cancer Res. 2019;25(4):1318–1330. doi: 10.1158/1078-0432.CCR-18-2297
27. Virgilio F. Di, Adinolfi E. Extracellular purines, purinergic receptors and tumor growth. Oncogene. 2017;36(3):293–303. doi: 10.1038/onc.2016.206
28. de Marchi E., Orioli E., Pegoraro A., Sangaletti S., Portararo P., Curti A., Colombo M.P., di Virgilio F., Adinolfi E. The P2X7 receptor modulates immune cells infiltration, ectonucleotidases expression and extracellular ATP levels in the tumor microenvironment. Oncogene. 2019;38(19):3636–3650. doi: 10.1038/s41388-019-0684-y
29. Kepp O., Bezu L., Yamazaki T., di Virgilio F., Smyth M.J., Kroemer G., Galluzzi L. ATP and cancer immunosurveillance. EMBO J. 2021;40(13):e108130. doi: 10.15252/embj.2021108130
30. Pietrocola F., Pol J., Vacchelli E., Rao S., Enot D.P., Baracco E.E., Levesque S., Castoldi F., Jacquelot N., Yamazaki T., … Kroemer G. Caloric restriction mimetics enhance anticancer immunosurveillance. Cancer Cell. 2016;30(1):147–160. doi: 10.1016/j.ccell.2016.05.016
31. Jiang Z.F., Wu W., Hu H.B., Li Z.Y., Zhong M., Zhang L. P2X7 receptor as the regulator of T-cell function in intestinal barrier disruption. World J. Gastroenterol. 2022;28(36):5265–5279. doi: 10.3748/wjg.v28.i36.5265
32. Dixit A., Cheema H., George J., Iyer S., Dudeja V., Dawra R., Saluja A.K. Extracellular release of ATP promotes systemic inflammation during acute pancreatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 2019;317(4):G463–G475. doi: 10.1152/ajpgi.00395.2018
33. Dwyer K.M., Kishore B.K., Robson S.C. Conversion of extracellular ATP into adenosine: a master switch in renal health and disease. Nat. Rev. Nephrol. 2020;16(9):509–524. doi: 10.1038/s41581-020-0304-7
34. Skorkina M.Yu., Shevchenko T.S., Fetter V.V., Cherkashina O.V., Palchikov M.Yu. Extracellular ATP molecules effects the functional properties of granulocyte plasma membrane. Geny i kletki = Genes and Cells. 2020;15(3):63–67. [In Russian]. doi: 10.23868/202011010
35. Orlov S.N., Smaglii L.V., Gusakova S.V., Rydchenko V.S., Birulina Iu.G., Baikov A.N., Vasilev V.N., Sukhanova G.A., Fedorova T.S., Lasukova T.V. Role of potassium conductance in mechanisms of extracellular ATP impact on the contractive activity of vascular smooth muscle cells. Byulleten’ sibirskoy meditsiny = Bulletin of Siberian Medicine. 2016;15(5):105–112. [In Russian]. doi: 10.20538/1682-0363-2016-5-105-112
36. Servuli E.A., Postovskaya A.M., Sapozhnikov A.M., Shevchenko M.A. Time-dependent variation of concentrations of extracellular ATP and heat shock protein 70 kda (HSP70) in induced allergic airway inflammation. Rossiyskiy immunologicheskiy zhurnal = Russian Journal of Immunology. 2014;8(3):398–401. [In Russian].
37. Mori Y., Shiratsuchi N., Sato N., Chaya A., Tanimura N., Ishikawa S., Kato M., Kameda I., Kon S., Haraoka Y., Ishitani T., Fujita Y. Extracellular ATP facilitates cell extrusion from epithelial layers mediated by cell competition or apoptosis. Curr. Biol. 2022;32(10):2144–2159.e5. doi: 10.1016/j.cub.2022.03.057
38. MacLeod A.S., Rudolph R., Corriden R., Ye I., Garijo O., Havran W.L. Skin-resident T cells sense ultraviolet radiation-induced injury and contribute to DNA repair. J. Immunol. 2014;192(12):5695–702. doi: 10.4049/jimmunol.1303297
39. Lalo U., Bogdanov A., Pankratov Y. Ageand experience-related plasticity of ATP-mediated signaling in the neocortex. Front. Cell. Neurosci. 2019;13:242. doi: 10.3389/fncel.2019.00242
40. Gaff J., Estiasari R., Diafiri D., Halstrom S., Kamerman P., Price P. Neurocognitive outcomes in indonesians living with HIV are influenced by polymorphisms in the gene encoding purinergic P2X receptor 7. Brain Behav. Immun. Health. 2021;13:100220. doi: 10.1016/j.bbih.2021.100220
41. Soare A.Y., Freeman T.L., Min A.K., Malik H.S., Osota E.O., Swartz T.H. P2RX7 at the host-pathogen interface of infectious diseases. Microbiol. Mol. Biol. Rev. 2021;85(1):e00055-20. doi: 10.1128/MMBR.00055-20
42. Xu R., Yuan L.S., Gan Y.Q., Lu N., Li Y.P., Zhou Z.Y., Hu B., Wong T.S., He X.H., Zha Q.B., Ouyang D.Y. Extracellular ATP contributes to the reactive oxygen species burst and exaggerated mitochondrial damage in D-galactosamine and lipopolysaccharideinduced fulminant hepatitis. Int. Immunopharmacol. 2024;130:111680. doi: 10.1016/j.intimp.2024.111680
43. Douguet L., Janho Dit Hreich S., Benzaquen J., Seguin L., Juhel T., Dezitter X. Duranton C., Ryffel B., Kanellopoulos J., Delarasse C., … Vouret-Craviari V. A small-molecule P2RX7 activator promotes antitumor immune responses and sensitizes lung tumor to immunotherapy. Nat. Commun. 2021;12(1):653. doi: 10.1038/s41467-021-20912-2
44. Kamata-Sakurai M., Narita Y., Hori Y., Nemoto T., Uchikawa R., Honda M., Hironiwa N., Taniguchi K., Shida-Kawazoe M., Metsugi S., … Igawa T. Antibody to CD137 activated by extracellular adenosine triphosphate is tumor selective and broadly effective in vivo without systemic immune activation. Cancer Discov. 2021;11(1):158–175. doi: 10.1158/2159-8290.CD-20-0328
45. Yoon M.J., Lee H.J., Kim J.H., Kim D.K. Extracellular ATP induces apoptotic signaling in human monocyte leukemic cells, HL-60 and F-36P. Arch. Pharm. Res. 2006;29(11):1032–1041. doi: 10.1007/BF02969288
46. Mimoto F., Tatsumi K., Shimizu S., Kadono S., Haraya K., Nagayasu M., Suzuki Y., Fujii E., Kamimura M., Hayasaka A., … Igawa T. Exploitation of elevated extracellular ATP to specifically direct antibody to tumor microenvironment. Cell Rep. 2020;33(12):108542. doi: 10.1016/j.celrep.2020.108542
47. Shi C., Chen M., Li X., Fu Y., Yang D., Wen T., Zhao W., Sun Y., Wang W., Lu C., … Quan G. ATPadenosine axis regulation combined with microneedle assisted photoimmunotherapy to boost the immunotherapy efficiency. J. Control. Release. 2024; 367:1–12. doi: 10.1016/j.jconrel.2024.01.035
48. Miras-Portugal M.T., Menéndez-Méndez A., Gómez-Villafuertes R., Ortega F., Delicado E.G., Pérez-Sen R., Gualix J. Physiopathological role of the vesicular nucleotide transporter (VNUT) in the central nervous system: relevance of the vesicular nucleotide release as a potential therapeutic target. Front. Cell. Neurosci. 2019;13:224. doi: 10.3389/fncel.2019.00224
49. Hasan D., Shono A., van Kalken C.K., van der Spek P.J., Krenning E.P., Kotani T. A novel definition and treatment of hyperinflammation in COVID-19 based on purinergic signaling. Purinergic Signal. 2022;18(1):13–59. doi: 10.1007/s11302-021-09814-6
50. Pacheco P.A.F., Faria R.X. The potential involvement of P2X7 receptor in COVID-19 pathogenesis: A new therapeutic target? Scand. J. Immunol. 2021;93(2):e12960. doi: 10.1111/sji.12960
51. Agteresch H.J., Dagnelie P.C., van der Gaast A., Stijnen T., Wilson J.H. Randomized clinical trial of adenosine 5′-triphosphate in patients with advanced non-small-cell lung cancer. J. Natl. Cancer Inst. 2000;92(4):321–328. doi: 10.1093/jnci/92.4.321
52. Beijer S., Hupperets P.S., van den Borne B.E., Eussen S.R., van Henten A.M., van den Beukenvan Everdingen M., de Graeff A., Ambergen T.A., van den Brandt P.A., Dagnelie P.C. Effect of adenosine 5′-triphosphate infusions on the nutritional status and survival of preterminal cancer patients. Anticancer Drugs. 2009;20(7):625–633. doi: 10.1097/CAD.0b013e32832d4f22
53. Rapaport E., Salikhova A., Abraham E.H. Continuous intravenous infusion of ATP in humans yields large expansions of erythrocyte ATP pools but extracellular ATP pools are elevated only at the start followed by rapid declines. Purineric Signal. 2015;11(2):251– 262. doi: 10.1007/s11302-015-9450-y
54. Coolen E.J., Arts I.C., Bekers O., Vervaet C., Bast A., Dagnelie P.C. Oral bioavailability of ATP after prolonged administration. Br. J. Nutr. 2011;105(3):357– 366. doi: 10.1017/S0007114510003570
55. Kichenin K., Seman M. Chronic oral administration of ATP modulates nucleoside transport and purine metabolism in rats. J. Pharmacol. Exp. Ther. 2000;294(1):126–133.
56. Kichenin K., Decollogne S., Angignard J., Seman M. Cardiovascular and pulmonary response to oral administration of ATP in rabbits. J. Appl. Physiol. 2000;88(6):1962–1968. doi: 10.1152/jappl.2000.88.6.1962
Review
For citations:
Patrakeeva V.P. The role of extracellular ATP in regulating the functional activity of cells. Сибирский научный медицинский журнал. 2024;44(5):53-60. (In Russ.) https://doi.org/10.18699/SSMJ20240506